Ignite Creation Date:
2024-05-06 @ 9:12 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02927340
Status:
UNKNOWN
Last Update Posted:
2021-03-09
First Post:
2016-09-26
Brief Title:
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
None
Primary Completion Date:
2022-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-26
First Submit QC Date:
October 5 2016
Study First Post Date:
2016-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-07
Last Update Post Date:
2021-03-09
Last Update Post Date Type:
ACTUAL